78 related articles for article (PubMed ID: 17551220)
1. A novel culture method of canine peripheral blood lymphocytes with concanavalin a and recombinant human interleukin-2 for adoptive immunotherapy.
Kato M; Watarai S; Nishikawa S; Iwasaki T; Kodama H
J Vet Med Sci; 2007 May; 69(5):481-6. PubMed ID: 17551220
[TBL] [Abstract][Full Text] [Related]
2. Bulk cultures of canine peripheral blood lymphocytes with solid phase anti-CD3 antibody and recombinant interleukin-2 for use in immunotherapy.
Itoh H; Kakuta T; Kudo T; Sakonju I; Hohdatsu T; Ebina T; Takase K
J Vet Med Sci; 2003 Mar; 65(3):329-33. PubMed ID: 12679562
[TBL] [Abstract][Full Text] [Related]
3. Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection.
Mie K; Shimada T; Akiyoshi H; Hayashi A; Ohashi F
Vet Immunol Immunopathol; 2016 Sep; 177():58-63. PubMed ID: 27436446
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.
Mitchell DH; Withrow SJ; Johnston MR; Kruse CA
Am J Vet Res; 1991 Jul; 52(7):1132-6. PubMed ID: 1892269
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis and effects of sequential administration of activated canine lymphocytes on healthy beagles.
Hoshino Y; Takagi S; Osaki T; Okumura M; Fujinaga T
J Vet Med Sci; 2008 Jun; 70(6):581-8. PubMed ID: 18628598
[TBL] [Abstract][Full Text] [Related]
6. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
7. Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis).
Masucci G; Svensson A; Hansson M; Hansson J; Nakazawa T; Salazar F; Petersson M; Kiessling R
J Hematother; 1997 Jun; 6(3):253-60. PubMed ID: 9234180
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.
Umiel T; Monselise J; Klein T; Rakovsky E; Fenig E; Lurie H; Adler A
J Biol Response Mod; 1989 Aug; 8(4):409-21. PubMed ID: 2787838
[TBL] [Abstract][Full Text] [Related]
9. Quality of life-improving effect of autologous ex vivo expanded cytotoxic and opioid-producing lymphocytes for dogs with cancers.
Mitani K; Ito Y; Takene Y; Hatoya S; Sugiura K; Inaba T
Vet Immunol Immunopathol; 2021 Aug; 238():110292. PubMed ID: 34246811
[TBL] [Abstract][Full Text] [Related]
10. Canine CD4(+)CD8(+) double-positive T cells can develop from CD4(+) and CD8(+) T cells.
Bismarck D; Moore PF; Alber G; von Buttlar H
Vet Immunol Immunopathol; 2014 Dec; 162(3-4):72-82. PubMed ID: 25454082
[TBL] [Abstract][Full Text] [Related]
11. Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma.
Gottlieb DJ; Micklethwaite K; Bradstock KF; Li YC
Cytotherapy; 2007; 9(2):133-43. PubMed ID: 17453965
[TBL] [Abstract][Full Text] [Related]
12. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
Roussel E; Gerrard JM; Greenberg AH
Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
[TBL] [Abstract][Full Text] [Related]
13. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
14. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
Liu S; Riley J; Rosenberg S; Parkhurst M
J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
[TBL] [Abstract][Full Text] [Related]
15. Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells.
Lee SH; Shin DJ; Kim SK
Vet Immunol Immunopathol; 2015 May; 165(1-2):1-13. PubMed ID: 25890849
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy.
Meehan KR; Wu A; Hassan R; Miao Y; Chawla J; Slack R; Gehan E; Herscowitz HB
J Hematother Stem Cell Res; 2001 Apr; 10(2):283-90. PubMed ID: 11359675
[TBL] [Abstract][Full Text] [Related]
17. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
19. Changes in lymphokine-activated killer activity in peripheral blood lymphocytes from canine transmissible venereal sarcoma models.
Mizuno S; Fujinaga T; Kurosawa T
Exp Anim; 1996 Jul; 45(3):289-92. PubMed ID: 8840150
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
